MECP2 and atypical Rett syndrome: The approach taken for Rett syndrome to overcome this problem, termed EXACT technology [21], is to incorporate into the viral genome the miRNA-binding sites used by the endogenous MECP2 gene to control the viral gene expression in each cell.